Rendering stone fragments paramagnetic by exposure to iron oxide-based microparticles shows promise as a novel approach for reducing the number of small retained fragments after ureteroscopic lithotripsy, say researchers who are developing the technology.
The RANK ligand inhibitor denosumab (XGEVA) may be able to prevent or at least delay multiple and/or symptomatic bone metastases in men with castration-resistant prostate cancer (CRPC) at high risk of bone metastases.
Functional recovery after partial nephrectomy correlated more closely with volume loss than with warm ischemia time, researchers from Cleveland Clinic's Glickman Urological and Kidney Institute recently reported.
A study from Duke University, Durham, NC suggests that folic acid may reduce the risk of prostate cancer recurrence following radical prostatectomy.
Controversies related to circumcision could lead to a rise in medical liability for urologists performing this procedure, writes the American Association of Clinical Urologists' Tim Lytle.
The difference in prostate cancer mortality among men with low-risk disease who choose active surveillance versus those who choose immediate treatment with radical prostatectomy is likely to be very modest—possibly as little as 2 to 3 months—a new research model has estimated.
Individuals with at least one symptomatic kidney stone episode have significantly heightened risks of end-stage renal disease (ESRD), chronic kidney disease, and sustained doubling of serum creatinine concentration, according to the results of a Canadian study.
New guidelines from the University of Michigan Health System, Ann Arbor, offer family physicians a step-by-step guide for the evaluation of urinary incontinence.
The FDA has approved the production and use of Choline C 11 Injection, a positron emission tomography agent used to help detect recurrent prostate cancer.
The 2012 Arthur D. Smith Endourology Lectureship has been awarded to Mihir Mahesh Desai, MD, DNB, director of the Center for Advanced Robotics at the University of Southern California Institute of Urology, Los Angeles.
The American Board of Urology (ABU) has joined several other member boards of the American Board of Medical Specialties (ABMS) in reporting publicly whether its physicians are meeting ABMS maintenance of certification requirements.
Researchers from the University of Southern California, Los Angeles have found a link between recreational marijuana use and an increased risk of developing subtypes of testicular cancer that tend to carry a worse prognosis.
The American Society for Radiation Oncology has submitted a letter to the Centers for Medicare & Medicaid Services opposing proposed policy changes for calendar year 2013 that would cut nearly $300 million for cancer treatment.
Taking aspirin is associated with a lower risk of death from prostate cancer, especially in men with high-risk disease, according to a recent multicenter study.
Academic Urology, a large urology group practice in eastern Pennsylvania, has signed a new 3-year contract with Independence Blue Cross (IBC) and is currently participating in IBC’s network.
A 2008 Medicare policy to stop payment for preventable, hospital-acquired conditions such as post-catheterization urinary tract infections has led to very little change in hospital payment, say researchers from the University of Michigan, Ann Arbor.
Prostate cancer in African-American men appears to be associated with specific changes in the IL-16 gene, according to researchers at the University of Illinois at Chicago College of Medicine.
A procedure designed to streamline robotic partial nephrectomy significantly reduces warm ischemia time (WIT) by nearly 25%, according to a recent analysis.
The FDA recently approved the oral androgen receptor inhibitor enzalutamide (Xtandi) for the treatment of patients with metastatic castration-resistant prostate cancer who have previously received docetaxel (Taxotere).
In Peyronie's disease patients, high levels of bother and distress are possible regardless of the degree of curvature, according to phase III data presented at the Sexual Medicine Society of North America (SMSNA)/International Society for Sexual Medicine (ISSM) joint annual meeting in Chicago.
AKSM, Ltd. commended the federal government’s recent decision to close its investigation and fully dismiss a qui tam complaint filed by a "whistleblower" against the company.
African-American men with prostate cancer receive lower quality surgical care than Caucasian men, according to a study led by researchers from Vanderbilt-Ingram Cancer Center, Nashville, TN.
New scientific evidence shows the health benefits of newborn male circumcision outweigh the risks of the procedure, but the benefits are not great enough to recommend routine circumcision for all newborn boys, according to an updated policy statement published by the American Academy of Pediatrics.
Prostate cancer screening decreases a patient's risk of developing metastatic disease, according to Cleveland Clinic researchers.
In the Halls of Power, Project Prevention, an incentivized sterilization program, has received a "pass." It will therefore be in the operating room where Project Prevention's solution will succeed or fail.
In the hands of high-volume surgeons, there is no evidence to suggest that robot-assisted laparoscopic prostatectomy results in worse oncologic outcomes then open radical prostatectomy, even in patients with high-risk cancer.
Men with previously treated castration-resistant prostate cancer (CRPC) lived almost 5 months longer when they received the androgen receptor signaling inhibitor enzalutamide.
With marijuana legalized for medical use in Canada since 2001 and now in 17 U.S. states and the District of Columbia, urology patients in pain have been turning to marijuana for relief.
